secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001193125-25-139517
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio prices $100M public offering of common stock and warrants to fund rese-cel development
--------------------------------------------------------------------------------

- Offering includes 39.2M shares and 50M warrants at combined price of $2.00 per unit; net proceeds ~$94M.
- Also offers 10.8M pre-funded warrants at $1.99999 per unit for certain investors.
- Underwriters have 30-day option to purchase up to an additional 15M shares and/or warrants.
- Proceeds to fund expanded clinical development of rese-cel, including potential registrational studies, and manufacturing readiness.
- Cash runway expected into second half of 2026 based on current operating plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312525139517/0001193125-25-139517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312525139517/d828604d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-139517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer